Clinical Trial Update: Fesoterodine on Urgency Episodes in Parkinson's Disease Population [Phase 4]

View source ↗

Summary

Phase 4 trial update on fesoterodine for urgency episodes in Parkinson's disease; study terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder
• Parkinson Disease

Drugs mentioned

• Fesoterodine (fesoterodine)

Snippet

Sponsor: Sir Mortimer B. Davis - Jewish General Hospital | Conditions: Urinary Bladder, Overactive, Parkinson Disease | Phase 4 | Status: TERMINATED